159 related articles for article (PubMed ID: 22989498)
1. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.
Carter LP; Reissig CJ; Johnson MW; Klinedinst MA; Griffiths RR; Mintzer MZ
Drug Alcohol Depend; 2013 Mar; 128(3):206-13. PubMed ID: 22989498
[TBL] [Abstract][Full Text] [Related]
2. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.
Reissig CJ; Carter LP; Johnson MW; Mintzer MZ; Klinedinst MA; Griffiths RR
Psychopharmacology (Berl); 2012 Sep; 223(1):1-15. PubMed ID: 22526529
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.
Barrett FS; Carbonaro TM; Hurwitz E; Johnson MW; Griffiths RR
Psychopharmacology (Berl); 2018 Oct; 235(10):2915-2927. PubMed ID: 30062577
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.
Carbonaro TM; Johnson MW; Hurwitz E; Griffiths RR
Psychopharmacology (Berl); 2018 Feb; 235(2):521-534. PubMed ID: 29116367
[TBL] [Abstract][Full Text] [Related]
5. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.
Carbonaro TM; Johnson MW; Griffiths RR
Psychopharmacology (Berl); 2020 Aug; 237(8):2293-2304. PubMed ID: 32500212
[TBL] [Abstract][Full Text] [Related]
6. Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers.
Carter LP; Kleykamp BA; Griffiths RR; Mintzer MZ
Psychopharmacology (Berl); 2013 Mar; 226(1):53-63. PubMed ID: 23096769
[TBL] [Abstract][Full Text] [Related]
7. Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers.
Carter LP; Griffiths RR; Mintzer MZ
Psychopharmacology (Berl); 2009 Sep; 206(1):141-54. PubMed ID: 19543883
[TBL] [Abstract][Full Text] [Related]
8. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
Johnson MW; Suess PE; Griffiths RR
Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
[TBL] [Abstract][Full Text] [Related]
9. Triazolam and zolpidem: effects on human memory and attentional processes.
Mintzer MZ; Griffiths RR
Psychopharmacology (Berl); 1999 May; 144(1):8-19. PubMed ID: 10379619
[TBL] [Abstract][Full Text] [Related]
10. Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers.
Kleykamp BA; Griffiths RR; Mintzer MZ
Exp Clin Psychopharmacol; 2010 Feb; 18(1):1-16. PubMed ID: 20158290
[TBL] [Abstract][Full Text] [Related]
11. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
[TBL] [Abstract][Full Text] [Related]
12. A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal.
Mintzer MZ; Griffiths RR
Psychopharmacology (Berl); 2007 Jun; 192(3):425-40. PubMed ID: 17342474
[TBL] [Abstract][Full Text] [Related]
13. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB.
Carter LP; Richards BD; Mintzer MZ; Griffiths RR
Neuropsychopharmacology; 2006 Nov; 31(11):2537-51. PubMed ID: 16880774
[TBL] [Abstract][Full Text] [Related]
14. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
[TBL] [Abstract][Full Text] [Related]
15. Psychophysiological effects and dose equivalence of zopiclone and triazolam administered to healthy volunteers. Methodological considerations.
Gorenstein C; Tavares SM; Gentil V; Peres C; Moreno RA; Dreyfus JF
Braz J Med Biol Res; 1990; 23(10):941-51. PubMed ID: 2101059
[TBL] [Abstract][Full Text] [Related]
16. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
Rush CR; Baker RW; Wright K
Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
[TBL] [Abstract][Full Text] [Related]
17. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.
Mintzer MZ; Frey JM; Yingling JE; Griffiths RR
Behav Pharmacol; 1997 Nov; 8(6-7):561-74. PubMed ID: 9832970
[TBL] [Abstract][Full Text] [Related]
18. Respiratory and sedative effects of triazolam in volunteers.
Longbottom RT; Pleuvry BJ
Br J Anaesth; 1984 Feb; 56(2):179-85. PubMed ID: 6140935
[TBL] [Abstract][Full Text] [Related]
19. Side effects of triazolam in children.
Coldwell SE; Awamura K; Milgrom P; Depner KS; Kaufman E; Preston KL; Karl HW
Pediatr Dent; 1999; 21(1):18-25. PubMed ID: 10029963
[TBL] [Abstract][Full Text] [Related]
20. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.
Mintzer MZ; Griffiths RR
Drug Alcohol Depend; 1998 Dec; 53(1):49-66. PubMed ID: 10933340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
